Harvest Fund Management Co., LTD Iovance Biotherapeutics, Inc. Transaction History

Harvest Fund Management Co., LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$7.59 - $17.47 $31,938 - $73,513	4,208 New	4,208 $62,000
Q4 2021 Feb 11, 2022	SELL	$16.55 - $27.63 $4,915 - $8,206	-297 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$28.67 - $52.59 $8,514 - $15,619	297 New	297 $9,000
Q2 2020 Aug 12, 2020	SELL	$27.21 - $41.0 $51,481 - $77,572	-1,892 Closed	0 $0
Q1 2020 May 08, 2020	BUY	$19.54 - $38.85 $36,969 - $73,504	1,892 New	1,892 $56,000

341

248M

4.04M

3.1M

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $879M
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

Get notified when there are updates to the investment portfolio of Harvest Fund Management Co., LTD, based on Form 13F filings with the SEC.

Stay updated on Harvest Fund Management Co., LTD with notifications on news.